James W. Denham - Concepedia

Author

James W. Denham

Also Known As

Denham, J. W., J DENHAM, J Denham, J W DENHAM, J W Denham, J. Denham, J. W. DENHAM, J. W. Denham, J.W Denham, J.W. DENHAM

373

Publications

12.6K

Citations

H-Index

160

Concepts

All Affiliations

University of Newcastle Australia Sir Charles Gairdner Hospital Calvary Mater Newcastle Hospital Peter MacCallum Cancer Centre Mater Misericordiae Hospital

About

James W. Denham is an author at University of Newcastle Australia specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	82	5.8K
2	Health Sciences	23	34	2K
3	Engineering	5	5	448
4	Management	1	1	64
5	Natural Sciences	1	1	12

James W. Denham

136

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Bryan Burmeister, B. Mark Smithers, Val Gebski, The Lancet Oncology Surgical OncologyResectable CancerEsophagusGastrointestinal OncologyEsophageal Cancer	2005	928
Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions Anthony V. D’Amico, James W. Denham, Juanita Crook, Journal of Clinical Oncology	2007	499
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial James W. Denham, Allison Steigler, David S. Lamb, The Lancet Oncology UrologyGenitourinary CancerMedicine10-Year DataAdvanced Prostate Cancer	2011	443
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial James W. Denham, Allison Steigler, David S. Lamb, The Lancet Oncology UrologyRadiation MedicineRadiation TherapyMedicineShort-term Androgen Deprivation	2005	376
An Atlas-Based Electron Density Mapping Method for Magnetic Resonance Imaging (MRI)-Alone Treatment Planning and Adaptive MRI-Based Prostate Radiation Therapy Jason Dowling, Jonathan Lambert, J. W. Parker, International Journal of Radiation OncologyBiologyPhysics EngineeringMedical ImagingBiomedical ImagingTreatment PlanningRadiation Therapy Planning	2012	307
Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases Daniel A. Galvão, Dennis R. Taaffe, Nigel Spry, Medicine & Science in Sports & Exercise	2017	222
A Multicentre Year-long Randomised Controlled Trial of Exercise Training Targeting Physical Functioning in Men with Prostate Cancer Previously Treated with Androgen Suppression and Radiation from TROG 03.04 RADAR Daniel A. Galvão, Nigel Spry, James W. Denham, European Urology Physical ActivityKinesiologyTrog 03.04Controlled TrialPhysical Fitness	2013	200
A generalized<i>F</i>mixture model for cure rate estimation Yingwei Peng, Keith Dear, James W. Denham Statistics in Medicine	1998	174
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial James W. Denham, David Joseph, David S. Lamb, The Lancet Oncology Zoledronic AcidUrologyTrog 03.04Radiation TherapyMedicine	2014	159
Fatigue during breast radiotherapy and its relationship to biological factors Chris Wratten, Janice Kilmurray, Sharon Nash, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineFatigue ManagementRadiation TherapyBreast RadiotherapyBrachytherapy	2004	159

Page 1